ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
143 hedge funds and large institutions have $699M invested in iTeos Therapeutics in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 34 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
32% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 28
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
143
Holding in Top 10
2
Calls
$201K
Puts
–
Top Buyers
| 1 | +$11.6M | |
| 2 | +$11.4M | |
| 3 | +$8.88M | |
| 4 |
Millennium Management
New York
|
+$7.88M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$3.88M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$11.1M | |
| 3 | -$10.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.06M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$4.56M |